C-VWJZCircumvent Pharma
precision medicines, palmitoylome modulation, neurodegeneration
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-VWJZ
C-VWJZC-VWJZprecision medicines, palmitoylome modulation, neurodegeneration
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Circumvent® PCV-M G2 (Merck) – QC Supply Skip to Main Content Skip to Footer Your cart is empty Continue shopping Have an account? Log in to check out faster. My Cart (0 items) You are being redirected to QC Supply Pharmacy, where you’ll find a wide selection of high-quality prescription and pharmaceutical products for animals of all sizes. Enjoy the same great service and expertise you trust from QC Supply. Click below to continue shopping. Continue No thanks, stay on the main site Powered by You’re being redirected to the QC Supply Pharmacy site. Continue No thanks, stay on the main si
SSO Bypass: How Attackers Circumvent Single Sign-On AI Security AI Security Featured Solutions AI Agent Security Supply Chain Security Audit and Compliance Use Cases Shadow AI MCP Security AI Prompt Security GenAI Data Leakage AI Threat Detection Capabilities Agent Visibility Agent Governance Agent Runtime Security AI-SPM Supported Platforms Amazon Bedrock Anthropic Claude ChatGPT Google Vertex Microsoft Copilot Microsoft Foundry n8n OpenAI Salesforce Agentforce View all integrations → SaaS Security SaaS Security Featured Solutions SaaS Supply Chain Security SaaS Security Posture Management Au … now known as Golden SAML, meant attackers could authenticate as anyone, to any application, without ever touching the identity provider's authentication flow. SSO had become the attack vector. Single sign-on systems serve as the master key to enterprise applications. When implemented correctly, SSO streamlines access, strengthens security posture, and simplifies identity management. But this centralization creates a paradox: the same mechanism that protects dozens of ap … mpelling reason: efficiency . A single successful bypass grants access to every application connected to that identity provider. Instead of compromising ten different applications individually, attackers compromise the authentication mechanism once and inherit access to everything. The mathematics of SSO bypass are brutal. Organizations typically connect 15-50 applications to their SSO provider. One forged SAML token means one attack yields access to all of them. This force m … Flow In a SAML implementation: User requests access to a service provider (SP) application SP redirects the user to the identity provider (IdP) IdP authenticates the user (username/password, MFA) IdP generates a SAML assertion containing user identity and attributes IdP signs the assertion with its private key User's browser delivers the signed assertion to the SP SP validates the signature using the IdP's public key SP grants access based on the assertion's c … icate from the identity provider can forge SAML assertions for any user, to any application, with any permissions-and these forged assertions are cryptographically indistinguishable from legitimate ones. How It Works The attack requires three steps: Compromise the IdP and extract the SAML signing certificate and private key Forge SAML assertions
Policy on questions asking for help to circumvent licensing laws - Tor Meta Stack Exchange Skip to main content Stack Exchange Network Stack Exchange network consists of 184 Q&A communities including Stack Overflow , the largest, most trusted online community for developers to learn, share their knowledge, and build their careers. Visit Stack Exchange s-popover#show" data-s-popover-placement="bottom-start" /> Loading… Back to Tor Stack Exchange Return to the main site Tour Start here for a quick overview of the site Help Center Detailed answers to any questions you might have What&#
The EU's ambitions need African resources: Can it disrupt Chinese-controlled supply chains? - ECDPM Topics Climate, energy and food Climate crisis Energy transition Food systems Economy and trade African economic integration Circular economy Finance and investment Private sector Trade Geopolitics and development AU-EU relations Digital cooperation EU foreign and development policy Health Multilateralism Governance AU and EU institutions Civil society Rule of law Migration and mobility Labour mobility Migration cooperation Return and reintegration Peace and security Conflict, fragility and resi
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
%PDF-1.3 %��������� 4 0 obj > stream x�U�n�0��+�TH$sE Ӹ �C�z(rHU; �,vҢ����D��"�) g�o�=����I�Ou?�K�,����p�hؒ�;�:۪�O�a-�����T�������_l�rT)�Í�1�L�����p��k$��1Ps�=æƻ���!��Z�Ѱ�=�$P?r�k\D��Y?(D�K�N��_%5T,JX�MI-�rU�����N%�Q��>��6�tf?�_!� �� ���N9Ǫ��e��UU\��{�T,��Dk yEi*��ERq���(��yi� e�$�;��G1�A'�Ͱ�{x �XO�MI��%��- VQ��b� �} �g^V)�T#�ow�L%��aBTi@8��4���K�9��2�del �+``��)� �A� ��j���������6nZJ�`�Z o��s����6�����%dB"M����| �+�� +c5f;�i*>1NT��1�g�ە��\ �L��i����3y�uIܽqG����Z��,�3���Q��N`�ιs ,��(�� ��VV,��z8̓�a���7�p�Z�� B�c�7��L��������%ʧO3�P� ԎiĀ�i�� … �I[�B � �f"4�+��8�t2�ʥ\�;#w�JG��m��A�您bS��@ �q&C��Cr�y)�0J���8Z��g�+�COCO�rFp) ��%~��b�u���0���ؤ5 V��w��T�)OOc���"04ckK"- ��P ����ı� ����Wij�u� ����ע�jo!XW�ۘk�{|��gsE��S�`"f! ƉЙڽ�MJ�*Y�Q��.{ �[���+j1hA-�'�62�-��8a2�r*� �ӂ���C9��` 2^'U�30�jc�A�8�~�'������(�]{s���I2*`l̕��Pwg��J� 9|�!�He� ���0�����T]�4N��|���tjs�E����PU��C��4S@BIT���(a͢ē ��Um%�� � �������Y����0��~2�e� Wx��$'S��,�~�ßB�*l~J٤�&�魋$=�=q�jW�& ��Ӣ֨�� p���B� *��]\��)�
Whiplash on SALT: A “technical” change in the House bill permits some taxpayers to continue using complex workarounds to circumvent the cap – The Tax Law Center Connect with us Search Keywords Topics Individuals and Families Energy and Climate Business and International IRS and Tax Administration Legislation Litigation Our Work Publications Blog Events In the News Tealbook Policy Options Tax System Explained About Us Donate Overview Our Team Advisory Board Careers Contact Us Home The Tax Law Center Blog Whiplash on SALT: A “technical” change in the House bill permits some taxpayers to co … law, that cap (and any of its mechanics, including phasedowns or limits) should apply to individual taxpayers as consistently as possible. There is no strong policy rationale for varying the application of the SALT cap by state, by industry, by the legal form a taxpayer’s income takes, or by whether taxpayers can afford tax advisors who can step them accurately through complex workaround techniques. However, it appears that House Republicans either did not intend the bill’s t … tment management companies. Under both versions of the bill, the SALT cap would apply to two types of payments: (1) certain enumerated state and local taxes (which we have called “normal” specified taxes or NSTs) and (2) certain other payments that qualify as “substitute payments.” Generally, substitute payments are payments to state or local governments that substitute for an enumerated NST—essentially, workaround payments. Both versions of the bill also define state and loc … l taxpayers will be retained. If that remains the case, Congress should seek to apply the cap as evenly, consistently, and administrably as possible. Owners of pass-through entities should not be able to selectively avoid the cap while everyone else remains subject to it. Blessing such avoidance is even more objectionable where it is only available to some owners of pass-through entities. Congress can still easily take a step in a much sounder policy direction by reverting to … izontal inequity by treating similar taxpayers differently—differing treatments apply across different states (based on whether, and how, states have enacted workarounds), and sophisticated filers are most able to understand how to utilize the workarounds and thus avoid the SALT cap altogether. Compared to lifting the SALT cap—which has benefits
Usability of non-medicinal swabs for SARS-CoV-2 detection to circumvent supply shortages Usability of non-medicinal swabs for SARS-CoV-2 detection to circumvent supply shortages Diagnosis (Berl) . 2020 Dec 21;8(3):398-399. doi: 10.1515/dx-2020-0135. Print 2021 Aug 26. Authors Günter Dollenmaier 1 , Remo Würth 1 , Esther Laternser 1 , Salome N Seiffert 1 , Wolfgang Korte 1 , Oliver Nolte 1 Affiliation 1 Center for Laboratory Medicine, St. Gallen, Switzerland. PMID: 33554512 DOI: 10.1515/dx-2020-0135 No abstract available Ke
Circumvent® G2 - Merck Animal Health USA Introducing Numelvi™ (atinvicitinib tablets) It’s time for an about-face icon: arrow-right Animal Health Professionals Producers Equine Owners and Professionals Products icon: down Products icon: arrow-right Featured products ALLFLEX® BRAVECTO® BOVILIS® INNOVAX® NOBIVAC® PRESTIGE® icon: arrow-left Back RESFLOR GOLD® REVALOR® SAFE-GUARD® SENSEHUB® SENTINEL® SEQUIVITY® VETSULIN® icon: arrow-left Back icon: arrow-left Back Pet Owners About Us icon: down About Us icon: arrow-right About Us icon: down About Us icon: arrow-right Company Statements Educa
%PDF-1.6 %���� 69 0 obj > endobj 90 0 obj >/Filter/FlateDecode/ID[ ]/Index[69 56]/Length 101/Prev 364773/Root 70 0 R/Size 125/Type/XRef/W[1 3 1]>>stream h�bbd```b``N� � ��DJ�H.�� ��� $ &��u�`��`�G`5� �QLz ���� ,�f����ޖ� �+`��0�������[� endstream endobj startxref 0 %%EOF 124 0 obj >stream h�b```�rV�� B ��ea�耉0 0L��(�p���A��FY�[f �[o�M`z����젰 �����"��(�ά�B�g�B��I� �|��(0�k�c� H\8x�q����3H]��+ ��*i > endobj 71 0 obj >/ExtGState >/Font >/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>> endobj 72 0 obj >stream h��[[oG��+� p�� �,;v+����|`d�&�, �����W��3 �"e�9�B�g�3�
Circumvent Polyethylene Supply Disruption | Shell Poylmers | Business
%PDF-1.6 %���� 53 0 obj >stream h�Ė�j�0 �_EO0[��8P[Ơ����0=d�) 4.I ��O��l���@�����C��$ �C�@VB�J@ �$p%�,/8�㡲Jj�@�R�#���lT:�A��@(�h1 �Z�ۮ ���D ��w�F2�V�}�܅�F��oN0�C~�ē?�ڿ�7m�^S��j�p��~�|�>�_�؈���X�ۣ�w������G�^�%�NU|�m�у�_ϮG_U�B��̴ �dF�ˑ]f�r92bffT �:7�I�.rC�����ة�bG��u�� ]$@����\MٛaB7����!�n��oG�Õ�Q���ah� ś�#�"��(�F��JE1Q�w�~-g�&4��~rU�-��' U endstream endobj 2 0 obj >stream H�*T0411PA C�����k�����`l� endstream endobj 3 0 obj >stream ����JFIF ����Adobed��� "$*$ $+(( $)%%1/%).*++9+*./45554/;;;;;;;;;;;;;;;;;;;;; $2(!(2;4222;;;;;;;;;;;;;;;;;@@@@@;@ … """ """ """ """ """ """ """ """ ""�� endstream endobj 44 0 obj >stream application/pdf Erin Lillis NAN 2025 Exhibitor and Sponsor Prospectus 2025-03-12T18:03:43Z Canva 2025-03-18T12:39:19-06:00 2025-03-18T12:39:19-06:00 DAGgOC_IG5k,BAFQVuH7e5o,0 Canva Yes uuid:73c829a4-c5ac-488c-98a8-b3423363d682 uuid:495fc7eb-d076-4f9b-9337-82eab2ea86c0 endstream endobj 45 0 obj > endobj 47 0 obj > endobj 48 0 obj > endobj 50 0 obj >stream H�*T0411PA C�����k�����`l� endstream e
Should we circumvent knowledge path dependency? The impact of conventional learning and collaboration diversity on knowledge creation --> --> --> Advanced search Economic literature: papers , articles , software , chapters , books . Authors Institutions Rankings Help/FAQ MyIDEAS More options at page bottom Economic literature Authors Institutions Rankings Help/FAQ MyIDEAS (now improved) --> Advanced search Browse Econ Literature Working papers Journals Software components Books Book chapters JEL classification More features Subscribe to new research RePEc Biblio Author registration Economics V … , Bronwyn H & Griliches, Zvi, 1984. " Econometric Models for Count Data with an Application to the Patents-R&D Relationship ," Econometrica , Econometric Society, vol. 52(4), pages 909-938, July. Jerry A. Hausman & Bronwyn H. Hall & Zvi Griliches, 1984. " Econometric Models for Count Data with an Application to the Patents-R&D Relationship ," NBER Technical Working Papers 0017, National Bureau of Economic Research, Inc. Haeussler, Carolin & Sauermann, Henry, 2020. " Division
Horse Sponsorships | Corolla Wild Horses | Corolla Wild Horse Fund Link to Facebook Link to Instagram Link to Youtube Instant Donate Join Today Shopping Cart Shopping Cart 0 Shopping Cart $ 0.00 --> Home Support the Horses One Time Donations Memberships Horse Sponsorships Owners are Donors Wedding Program Habitat Preservation Initiative Legacy Society Hay For a Day Volunteer Community Cares Learn Spanish Mustang History Corolla Wild Horse Fund History Herd Management Rescue & Rehabilitation Mustang Mornings FAQs Currituck County Ordinances, NC Laws, Federal Laws Legislation Community … Next Next 1 2 3 4 5 6 BETSY DOWDY EQUINE CENTER In 2018, the Corolla Wild Horse Fund purchased a 31-acre farm on the Currituck mainland in Grandy. Since then, dozens of Banker horses in need of rescue or removal from the wild in Corolla have been brought to our farm, the Betsy Dowdy Equine Center, for medical care, rehabilitation, and sanctuary. While some of the rescued horses in past have been candidates for adoption, many of the horses at the farm today require specialized … OR A BANKER More than 20 Bankers currently reside on the farm, dependent on the Fund, our small staff, and donors like you for the best of care. Over the years, our horse sponsorship program has had a significant impact on our ability to meet each horse’s needs with ease. By sponsoring a Banker, you help cover costs of rescue, veterinary treatment, medicine, hay, horse trailer maintenance, and essential upkeep of our barns and pastures. ENVIRONMENTALLY FRIENDLY In an effort t … ratches. Sponsor Now LOUIE Born: 2000 Removed from wild: Early 2000s Before the Fund switched over to using non-hormonal contraception to manage the wild horse population, colts were removed from the herd and adopted out as needed. Louie is part of the last group of horses removed for this reason, making him one of the few horses on the farm not removed due to illness, injury, or habituation. Louie was adopted out as a young horse but returned to the Fund in 2022 and will sta … Habitat Preservation Initiative Legacy Society Hay For a Day Corolla Wild Horse Fund 1130E Corolla Village Road Corolla, NC 27927 (252) 453-8002 MUSEUM & GIFT SHOP OPEN FOR THE SEASON: Monday – Saturday: 10am – 4pm Sunday: Closed PAGES Home Support the Horses Learn News Events Community Cares Community Toolkit Job Opportunities S
#awssummit #sydney #cloudsecurity #ai #circumvent | Michael Watts LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Pri
%PDF-1.5 %���� 73 0 obj > endobj 92 0 obj >/Filter/FlateDecode/ID[ ]/Index[73 44]/Info 72 0 R/Length 99/Prev 531325/Root 74 0 R/Size 117/Type/XRef/W[1 3 1]>>stream h�bbd```b``Z"+��:ɖ"���H�S`�)XD��& �E��&\�L[VI�5`s4A"�^p6������� h� �Pf��� �k^ S endstream endobj startxref 0 %%EOF 116 0 obj >stream h�b``d``*```�`��� �����YL�5� ��"�2�g�k��a��� Uu�`%����`�qp8@Le~7h��S�]� ��= endstream endobj 74 0 obj >/Metadata 2 0 R/Pages 71 0 R/StructTreeRoot 6 0 R/Type/Catalog>> endobj 75 0 obj >/MediaBox[0 0 612 792]/Parent 71 0 R/Resources >/Font >/ProcSet[/PDF/Text/Imag … ��ze� � 1�?���R��*� �y����ŗ���n��ø�o�V������u��Qj����~��>� 7�>��f> >stream application/pdf Owner 2017-01-15T09:24:55-05:00 Microsoft® Word 2010 2022-09-17T13:30:03-04:00 2022-09-17T13:30:03-04:00 Microsoft® Word 2010 uuid:b761c4e4-9537-4bfb-ab40-0b9e976e46aa uuid:ed8da9af-21a4-42d9-bb0a-c8eac865c2a5 endstream endobj 3 0 obj >stream h�27T0P���w�/�+Q0���L)�67 ��T��$�����c � endstream endobj 4 0 obj >stream h�t˱ �0�Wɦ��.�`��Uڭ����xp�����Z�u������q�w���\�V��iʋ�
Exhibitor deletes myid file Groups Groups Conversations All groups and messages Send feedback to Google Help Training Sign in Groups Groups exhibitor-users Conversations About Privacy • Terms     Exhibitor deletes myid file 670 views Skip to first unread message  Jason Kolb unread, May 30, 2013, 6:02:47 PM 5/30/13    Reply to author Sign in to reply to author Forward Sign in to forward Delete You do not have permission to delete messages in this group Copy link Report message Show original message Either email addresses are a
Elastic License 2.0 | Elastic Skip to main content New Forrester Wave Leader, Q2 2025 Access report About us Partners Support | Login Elastic logo Elasticsearch Elasticsearch for... Context engineering Get the most relevant context to agents so that they deliver accurate and trusted outcomes Vector database Efficiently create, store, and search vector embeddings Search powered applications The speed, scale, and flexibility to power modern application experience Logs Collect, search, explore, and act on large volumes Threat protection Detect, investigate, and remediate cyber threats at scale on
WebbStock Vendor/Exhibitor - Gardner-Webb University Skip to content Academics Colleges and Schools All Programs Graduate Programs Undergraduate Programs Gardner-Webb Online Programs Pre-Professional Pathways Searight Professional and Continuing Education (PACE) Enrichment Programs Academic Catalog Degree Plan Academic Success Advising Peer Tutoring and Writing Support Admissions and Aid Undergraduate Students Graduate Students Gardner-Webb Online Students Welcome Transfer Students Dual enrollment Estudiantes de habla hispana Financial Aid Scholarships and Grants Visit Our Campus Accessibility … and Service Career Center Counseling Services Division of Student Success Visit Apply Give News Directory Request Information Library MyGWU Campus Bookstore Campus Map Accessibility Registrar Services Academic Calendar & Events Job Openings Virtual Tour Athletics Degree Plan About Offices and Departments GWU History Mission and Vision Live Mascot Program Strategic Plan Community Facilities Publications Policies and Information Recognition Academics Colleges and Schools A … ic Calendar & Events Job Openings Virtual Tour Athletics Degree Plan Visit Apply Give News Visit Apply Give News WebbStock Vendor/Exhibitor Home / WebbStock Vendor/Exhibitor Page Sidebar The 2026 Webbstock Music Festival will be held August 22, 2026. The festival takes place at Brinkley Amphitheater and features an assortment of regional craft, food vendors, and a kids zone as well as various exhibitors and entertainment. Vendor spaces are assigned on a first come first … y not be reassigned or sublet by vendor. To guarantee space in the event please submit your payment by July 22, 2026. The University observes a strict no refund policy after an application has been processed. Submit Payment * If purchasing more than two additional spaces, please contact Lesley Villarose at (704) 406-2081. Company/Organization Name (required) Applicant Name (required) Applicant Email (required) Select Vendor Space Option (required) — $75 for single space … ace + $50 for additional two spaces Payment information is taken after clicking submit Total: $0 Give Request Info Apply 110 South Main Street P.O. Box 997 Boiling Springs, NC 28017 (704) 406-4000 Main About Academics Admissions and Aid Resources Student Life University Police Campus Map Utility Athletics Accessibility Title IX Compliance Directi
Check out this podcast on... - Academy for Eating Disorders Facebook Log In Academy for Eating Disorders's Post Academy for Eating Disorders January 11, 2020 · Shared with Public Check out this podcast on how to circumvent the risks of developing an eating disorder. edcatalogue.com Podcast Archives - Eating Disorders Catalogue Feature, Podcast Episode 171: Dr. Michael Levine, Dr. Tamara Pryor & Brogan Rossi: Circumventing the Risks of Developing an Eating Disorder January 6, 2020 | No Comments | More All reactions: 7 4 shares Like Comment
Licensing in Maximo Application Suite 9.0 and earlier Licensing in Maximo Application Suite 9.0 and earlier The Licensing Guidance provides information about licensing and entitlements for IBM® Maximo® Application Suite . Note: This Licensing Guidance is intended to provide only supplementary information to assist you in deploying the Program(s) you have licensed from IBM within your purchased entitlement. Your license agreement (such as the IBM International Program License Agreement (IPLA)) or equivalent and its transaction documents, including the License Information for IBM Maximo Applicat … m. Listing of licenses by type What do you get with your purchase of IBM Maximo Application Suite, and what is your entitlement? License ratio & user type Offering-specific licenses Non-production instances Additional terms for service providers Cloned or custom applications Back-up and restore Licensing requirements for indirect access scenarios Appendix: Modules & applications Note: The Licensing Guidance is also available in PDF . Maximo Application Suite uses: App … 's Authorized Use of the Program. Red Hat® OpenShift® All deployments of Maximo Application Suite that are deployed on Red Hat OpenShift Container Platform must have sufficient entitlement for the Maximo Application Suite cores that are used. Listing of licenses by type See also IBM Maximo Application Suite 8.11 (L-XSNF-SHG8GG) IBM Maximo Application Suite 9.0 (L-GRJQ-AJY62V) The following license types are used for AppPoints in Maximo Application Suite : Concurrent user Auth … ner directly or indirectly (for example: via a multiplexing program, device, or application server) through any means. Authorized user A unit of measure by which the Program can be licensed. An Authorized user is a unique person who is given access to the Program. The Program may be installed on any number of computers or servers and each Authorized User may have simultaneous access to any number of instances of the Program at one time. The licensee must obtain separate, dedi … directly or indirectly (for example, through a multiplexing program, device, or application server) through any means. An entitlement for an Authorized user is unique to that Authorized User and may not be shared, nor may it be reassigned other than for the permanent transfer of the Authorized user entitlement to another person. Access for Concur
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Terms and Conditions for Exhibitors and Sponsors | Oncology Nursing Society Skip to main content I Want To Login Donate Visit the ONS Store Verify Provider Card or Certificate Print my NCPD Certificates Login to my ONS Courses Explore Group Purchasing Login Donate Search I Want To Login Donate Visit the ONS Store Verify Provider Card or Certificate Print my NCPD Certificates Login to my ONS Courses Explore Group Purchasing Login Donate Search Membership Toggle submenu Back Join ONS Login Member Benefits About ONS Toggle submenu Back Mission, Vision, and Values Connie Henke Yarbro Oncology Nurs … r (“Company”) agrees and intend to be legally bound to these Terms. These Terms apply to both in-person and online/virtual events, but some provisions may be inapplicable depending on the type of event. For purposes of these Terms, the following terms have the following meanings: (a) “Event” means an event organized by ONS or its agents or designees, whether in-person (e.g., ONS Congress or ONS Hill Days) or online/virtual (e.g., ONS Bridge); (b) “Event Activity” means … tified on the Event Hub. 1. Applications 1.1. Applications . Company must apply for Company’s Event Activity. The individual who applies on Company’s behalf is deemed to be authorized to act on Company’s behalf and bind Company to these Terms. If the individual is engaged by a third party acting on Company’s behalf, the third party is deemed to be authorized to act on Company’s behalf and bind Company to these Terms. Company is deemed to have applied for an Event Activi … Terms. Company is deemed to have applied for an Event Activity by submitting an application, attaching an application to a written agreement, referencing the Event Activity in a written agreement, or otherwise seeking to enjoy the benefits and privileges associated with the Event Activity, in any case regardless of whether Company has filled out the application, signed the application, or attached the application to the written agreement. 1.2. Denied Application … ent. 1.2. Denied Applications . ONS reserves the right to deny an application in its sole discretion, in which case, ONS will notify Company and refund any fees paid in connection with the application at issue. 1.3. No Sharing . Company cannot share, transfer, sublet, or assign Company’s Event Activity. Any attempt to do so wi
%PDF-1.7 %���� 1 0 obj >/Metadata 247 0 R/ViewerPreferences 248 0 R>> endobj 2 0 obj > endobj 3 0 obj >/ExtGState >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 612 792] /Contents 4 0 R/Group >/Tabs/S/StructParents 0>> endobj 4 0 obj > stream x��\�S��� ��?& b��%wv2t�,�ˆ���� a�mb��i��}�9� '�a7�ww~H���t^R8 :+�r���Q�����q�eijX�',N�W̌�����|��{_��x��wxƢ4��h���Ǣ������MF�9��ᣎ>/����3�w�����=i������;�!� ���L6) `�7 fbλ�2� ���D`P���'Y"c�š&� �!3����c������,^'�/c H�Sg� ^4qgq�#�c!}���ծ(�_v������l$ �%%���(���^��O�dm�v#��^�Ƨ�?��꾯{���E7x G�� L�/=�`:�� H�L�XtQ�%5O ,�
%PDF-1.6 %���� 387 0 obj > endobj 395 0 obj >/Filter/FlateDecode/ID[ ]/Index[387 16]/Info 386 0 R/Length 59/Prev 663807/Root 388 0 R/Size 403/Type/XRef/W[1 2 1]>>stream h�bbd``b`�$��� !a$���'H"H�\����(�20b%�3��0�i� endstream endobj startxref 0 %%EOF 402 0 obj >stream h�b```"v�,!b`a`b��F %�� �Ō�� x3�[� ���2;5��v��Ka�=p;�� �mfO� � ����� ���3�c�4���x��ё��l /� �� T~��b�=X5A�� f� �S��Ys �6�����V��Pr@J�u�A��5BI g %�00�55rO����c�o�t萘ȼ�Q遚����[���4 ��. ���.p�k����-�����EaYA�kG\���X�ĭ'.dz'��ѓ``�`�h`@��0�d H� )Pj`�9 �)��8ӁJ��b�n�Wpl�:� i� … -.s��[����Q����o���������.�_�.�j� ,Q;� endstream endobj 251 0 obj >stream application/pdf 2019-05-18T03:43:27Z Word 2019-05-21T12:41:43-04:00 2019-05-21T12:41:43-04:00 macOS Version 10.14 (Build 18A391) Quartz PDFContext uuid:c467eb8d-b295-4e74-be93-259b4cda3d29 uuid:82cf52df-0a54-4db1-baf0-a3fb9ef7f60e endstream endobj 252 0 obj >stream hޜ�=O�0E��a�߇���� #KU�U *Q!@�=N|�DR��(���ϩS-B��(ek0b��L"�� ��c�|�9s(�P̡�W��O�������Z�>� endstream endobj 253 0 obj >stream
Licensing Models for Modern On-prem | ModernOnPrem Onprem.org is still in preview mode. Join the community for launch updates. Introduction Enterprise Guide Vendor Guide Technical Considerations Operational Considerations Modern On-prem vs Traditional On-prem Modern On-prem vs. SaaS Cross-Functional On-prem Delivery Licensing Models for Modern On-prem Disconnected Troubleshooting Release Management Vendor FAQ Resources About Join the Community Licensing Models for Modern On-prem What to protect When packaging an application to be deployed to a Modern On-prem environment, there are a number of … ating and enforcing product assortment . Limiting the number of instances of an application that can be run by a single end user. While running on-prem software in an internet-connected environment makes a lot of this much easier to enforce, Modern On-prem means embracing variety of deployment targets . This includes Airgapped environments with no outbound connection. Because of the variety of targets, this licensing conversation is focused on ways to do enforcement when an a … ncompass: Risk that an end customer will violate a software contract and use an application after they are not licensed to do so, or enable features they are not paying for. Risk that an end customer will accidentally or intentionally leak an application’s source code, configuration, or binary artifacts. In all three cases, we’ll find that the effort applied by the vendor to secure the software usually matches the effort required by the end customer to circumvent … for vendors is low. While the other trust levels might require some changes to application code and architecture so that licensing can be enforced at runtime, high trust environments don’t generally need these measures. Similarly, the effort for end users to circumvent is low – it should be fairly trivial for an end user who acquires the application artifacts and configuration to run them without acquiring a proper license. Low Trust When giving out software to g … nsidering a Low Trust licensing models. In this case, vendors should instrument application code with licensing logic to validate that the user running the application code is authorized to do so. Most implementations of the low-trust model involve some version of: Vendor embeds a public key in the application artifact, obfuscating the contents o
Syrian Opposition Won't Participate In Russian-Sponsored Congress Accessibility links Skip to main content Skip to main Navigation Skip to Search Next Close Previous Next This image contains sensitive content which some people may find offensive or disturbing. Click to reveal Print Options: Images Multimedia Embedded Content Comments Cancel Print Link has been copied to clipboard MORE To Readers In Russia Russia Russia Tatar-Bashkir North Caucasus Iran Central Asia Kazakhstan Kyrgyzstan Tajikistan Turkmenistan Uzbekistan South Asia Afghanistan Pakistan Caucasus Armenia Azerbaijan Georgia … ition for the war-torn country. Turkey and Iran on October 31 endorsed Russia's proposal to host talks between the Syrian government and its opponents next month in Sochi to try to move the war-torn country toward a political settlement. The congress proposal was one of the few notable outcomes from the seventh round of talks on Syria held in the Kazakh capital, Astana, on October 30 and 31. "The coalition will not participate in any negotiations with the regime outside … at the plenary session in Astana on October 31. Kurdish groups were open to the proposal, however. "We are studying the issue and our stance has been positive so far," Badran Jia Kurd, an adviser to the administration that governs Kurdish-led autonomous regions of Syria, told Reuters. While the Astana talks have had some success establishing limited cease-fires and no-conflict zones amid ongoing battles, the Geneva talks so far have not led to either lasting cease-f
Federal Register :: Request Access Request Access Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Please visit FederalRegister.gov API documentation or eCFR.gov API documentation to learn more about how to access the API. Your request has been flagged as potentially automated. If you are human user receiving this message, please complete the CAPTCHA (bot test) below and click "Request Access". You may occassionally be asked to complete the CAPTCHA again, this is normal and part of
%PDF-1.4 %���� 1 0 obj > endobj 3 0 obj > endobj 7 0 obj > stream x����J�`��Ԃ(�� 28�h��mRpi#�V!�S�� �IHS�tspu+.ހ�e(��%���| �:t����� �� � @V�� G�zM�� �&|)�4c�Ƃ��� � �ٛbw��0�o�Π?�һY���M�֩УO� > stream x���$Wy�Q�� ���}��'�XH� 0 ���3�4��w$���-�A̎�7k��#+K�"���B���X�n�[0kI�����>뱄ߠ��=�����̈�7����yNwUVdčϽ7�{�x�s��NRi+�ݕ�n���_�ާ���p�O��2���u���;�2��d�j^iV���ӯ�C�g�� � ����_f�,� P� -,F�ڴ� �.g�S�su �y镃��?0.j����U�B�;ڔ��ؽ� ����n�r; �ſ�����5���?������@�EG� ���=${�{�4�����Z�47�oF��Z]m�4̀78Ba�8 ^�*[=�^����ޘ�rk��Rxj[ýįM�ٰk}Wg6��A��g��]Ǫ�����K���u��S1,��ST�J �� �
%PDF-1.7 %���� 3941 0 obj > endobj xref 3941 18 0000000016 00000 n 0000011317 00000 n 0000011485 00000 n 0000011578 00000 n 0000011616 00000 n 0000012584 00000 n 0000012613 00000 n 0000012853 00000 n 0000013186 00000 n 0000013301 00000 n 0000013340 00000 n 0000015990 00000 n 0000016100 00000 n 0000016154 00000 n 0000031200 00000 n 0001601719 00000 n 0001602046 00000 n 0000000656 00000 n trailer ]/Prev 50421003>> startxref 0 %%EOF 3958 0 obj >stream h��zy\S�> cd`4�yl�$ � �@�T� "F����moq�k'T;]#��ֶA�zkoA@쌊C{�Z���m��'��}�m??_?�w����O�����������O `@�VL�B��G��0��gDtrl����鿲E�"y�H�A� … i�ԧ T:�tى�C�XF'o� �dsj"ha|s��yZ\Ap#v~�4���ͼ �e���"dM`=[��fsA� x���m���rfP�J�-�X�$�����=Tҷ����m� �� $Ξ�4*& �cA�!�� 7��/p�]tnz|l�zd��� Zh�tN�({Ik�XC��Kr�s�kpk�y�*Y��s��$ı*���w��L��]��9���r-���]�cK�_�Ē������n0���� MKi#��� �d����:��m��Z1�q:gDzp��q��B�y�#+'#��Y������\O��GE������J���Γ��- ���{[]��* ���l��c�6\�/�_X��[cdk���[l���}v�wq�Fkt���rb/{]��������nc� ӓ~��>��`�-�Z�H6?�or�����`���[H��~A � A� �aĀl ���i Z�����R���H�%N[ӌg!������?b�����ྗd�R�k�� … 25-04-03T13:58:17-04:00 2025-04-03T13:58:17-04:00 pdfplot16.hdi 16.01.051.00000 application/pdf 11x17 horiz uuid:512ce0e0-1a36-4b10-92fc-857734c7dd9c uuid:a8f98fc1-5554-4969-89ab-19b9084c9c7c proof:pdf 1 True False 17.000000 11.000000 Inches ArialMT Arial Regular Open Type Version 5.01.2x False Arial.ttf DINPro-CondBold DIN Pro Condensed Bold Open Type Version 7.504; 2005; Build 1005 False DINPro-CondBold 2.otf DINPro-CondBlack DIN Pro Condensed Black Open Type Version 7.504; … Group 0 Adobe Illustrator endstream endobj 117 0 obj > endobj 118 0 obj >stream application/pdf ab271843-897c-4988-8d8f-cb80e56484de Adobe Illustrator 29.3 (Macintosh) 2025-04-03T16:10:35-04:00 2025-04-03T16:10:35-04:00 2025-04-03T16:10:35-04:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:f1cee0fc-fdf1-44c6-b699-76b3dca1e609 uuid:32ec5430-97dc-fe4b-b895-f5a3a63ec986 uuid:27f584af-a488-9349-a64a-b29a9af20ed9 xmp.did:8d08eb9c-7571-4e78-aade-d88bdc677e5e uuid:65E6390 … +� endstream endobj 158 0 obj > endobj 159 0 obj > endobj 160 0 obj >stream application/pdf ab271843-897c-4988-8d8f-cb80e56484de Adobe Illustrator 29.3 (Macintosh) 2025-04-03T16:10:35-04:00 2025-04-03T16:10:35-04:00 2025-04-03T16:10:35-04:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:f1cee0fc-fdf1-44c6-b699-76b3dca1e609 uuid:32ec
%PDF-1.7 %���� %ABCpdf 11312 649 0 obj > endobj xref 649 33 0000000032 00000 n 0000001613 00000 n 0000001783 00000 n 0000001833 00000 n 0000002232 00000 n 0000002594 00000 n 0000002750 00000 n 0000002782 00000 n 0000002969 00000 n 0000003050 00000 n 0000003330 00000 n 0000003393 00000 n 0000003456 00000 n 0000003654 00000 n 0000003915 00000 n 0000004108 00000 n 0000004364 00000 n 0000004515 00000 n 0000004547 00000 n 0000004729 00000 n 0000004810 00000 n 0000005085 00000 n 0000005285 00000 n 0000005552 00000 n 0000005959 00000 n 0000006240 00000 n 0000006543 00000 n 0000006998 00000 n 00000074 … s�/���p���E�ܱ��� ��ݷ6���[� k�3D�8$Sg1��욻��� p3�[s�u��4�����8J=(��X@���Rfp=�Dg(�7��f(B�����i��|�f5�̚�&c�0�1����uF�ْ����PzG8OC�;�(� �߀$�%���u�����,�jSԬŎ2(�R3�`�`�|�+��k �y�Sǫ^u �&w��w�G�ܾ19��n����������Y,\�Z�^-�l��z���=�#�#��ٗ]/��w�� }�|�r8��������n^t��z�3ų�� �� ]^���id97�i�� j�JE�nh�����(if�� ��$����H���4�`�f���ؖ���:l�-x͆ ~�R!-���C=!� 3��/ǂe- '{[�Z����n}���S/��g�ʟ�>)UU�Fx�i�t`ퟢtz �D�l�F�'�&�g��7DPV6�L�5��� ���T�;"�R�GOEO�^N�
National Institutes of Health--Food at Government-Sponsored Conferences | U.S. GAO Skip to main content U.S. Government Accountability Office Menu Reports & Testimonies Reports & Testimonies Recommendations Database Month in Review Order Copies Restricted Reports View Topics View Agencies Bid Protests & Appropriations Law Bid Protests & Appropriations Law Bid Protests Appropriations Law Federal Vacancies Reform Act Congressional Review Act Other Legal About About What GAO Does U.S. Comptroller General Careers Contact Us For Congress Press Center Careers Blog Breadcrumb Home Leg … ls, as well as certifying officers, agency auditors, and Inspectors General, to apply these criteria. To the extent that agency officials are uncertain as to the applicability of the criteria in particular circumstances, they may request a decision from this office, pursuant to 31 U.S.C. 3529, before proceeding. DECISION Pursuant to 31 U.S.C. 3529(a), a certifying officer at the National Institutes of Health (NIH) requested an advance decision regarding the use of appropriate … -233807, Aug. 27, 1990; B-198471, May 1, 1980. We think similar criteria should apply to determining whether the costs of meals or refreshments are allowable expenses of the agency hosting a formal conference. As the discussion above indicates, we have long permitted agencies, under appropriate circumstances, to cover their employees' costs of meals when attending formal conferences. 38 Comp. Gen. 134 (1958); B-198471, May 1, 1980; B-154912, Aug.26,1964. Further, we have perm … personal expense, food. It is important to note that these criteria necessarily apply on a case-by-case basis. Before implementing this decision, an agency should develop an agency policy specifying the types of formal conferences at which the agency may consider providing food, consistent with the criteria contained in this decision. An agency also should develop procedures to ensure that the provision of meals and refreshments meet the criteria listed above. We expect agenc … ls, as well as certifying officers, agency auditors, and Inspectors General, to apply these criteria. To the extent that agency officials are uncertain as to the applicability of the criteria in particular circumstances, they may request a decision from this office, pursuant to 31 U.S.C. 3529, before proceeding. Registration fees to cover expense
Biophysics at Notre Dame // University of Notre Dame Skip To Content Skip To Navigation Skip To Search University of Notre Dame College of Science Biophysics at Notre Dame Academics Faculty Research Facilities News & Events About Menu Search Search News 5/26/2026 Douglas and Diana Berthiaume make groundbreaking gift to support strategic investment in biomedical research infrastructure Author: Erin Blasko Douglas and Diana Berthiaume have made a transformational gift to the University of Notre Dame to advance biomedical research through strategic investments in critical infrastructure. The … 5/06/2026 Department of Chemistry & Biochemistry Among 2026 Canvas Legends Award Winners Author: Laura Cira When Notre Dame students go to access their course materials online, it’s highly likely their instructor is sharing them through the Canvas learning management system. The Canvas Legends Awards, sponsored by the Office of Information Technology’s Teaching & Learning Technologies team, place the spotlight on faculty turning that seemingly routine tas … ead More about Department of Chemistry & Biochemistry Among 2026 Canvas Legends Award Winners Posted In: Research 4/02/2026 Notre Dame researchers to advance detection and community knowledge of opioids, including new variants Author: Monica Sayler Four teams of researchers across the College of Science and the College of Engineering have been selected to receive seed funding from the Notre Dame Sensor Initiative (NDSI) for research advancing affordable, fast, and accurate pl
Caution to Private Equity Firms Acquiring Competing Portfolio Companies CookieSettings Logo Main Content Main Menu Search Menu About Us Careers Offices Professionals Professionals Search Professionals Firm Leadership Services Services Antitrust and Trade Regulation Antitrust and Trade Regulation Antitrust and Trade Regulation Litigation Bankruptcy, Restructuring and Distressed Situations Bankruptcy, Restructuring and Distressed Situations Workouts and Restructuring Corporate and Business Organizations Corporate and Business Organizations Business Organizational Matters, Including Entity Select … l, mezzanine funds and hedge funds, sponsors, family offices, investment firms, fund investors, senior and subordinated debt lenders and portfolio companies in all aspects of fund and entity formation, operation and fundraising, M&A and joint ventures, leveraged lending, recapitalizations and other debt and equity finance transactions, as well as other comprehensive full-service legal matters. Our private equity transactional experience ranges from $1 million to more than … quity Jump to Page Publications Vorys Benefits Brief: Retirement Plan Amendment Deadline Looming Publications Many retirement plans must be amended by December 31, 2026 to bring the plan document into compliance with a number ... News Havens Quoted in Law360 Story on ACA Ruling, Impact on Future CMS Changes News She discussed a recent court ruling regarding the Affordable Care Act (ACA). Publications Court Strikes Down $100,000 H-1B Entry Fee, But Fee Still Applies Pendi
Strategic Pharmaceutical Investment Strategy And Services Skip links Skip to primary navigation Skip to content Toggle navigation Who We Are KreaMedica KreaConnect KreaMedica Holdings Expertise Biologics Cellular and Gene Therapy Products Central Nervous System Combination Drugs Drug Conjugates General Toxicology Inhalation Toxicology Small Molecules Vaccine Development Investment Portfolio Events Content Hub Blog Articles Ebook Case Studies Contact Us Get Started Strategic Investments KreaMedica Holdings Inc. represents a new breed of biotech investor grounded in the principle of “smart money … WS Please enable JavaScript in your browser to complete this form. Your Email * Submit Copyright © 2026 KreaMedica Disclaimer Privacy Policy
Teacher Adapts Curricula to Circumvent Institutional Discrimination – Podcast Episode 183 - IDRA Close Menu Home Donate Who We Are About IDRA Change Model President & CEO Staff Staff Team Home Mikayla Arciaga, M.A.Ed. Nilka Avilés, Ed.D. Hector Bojorquez Morgan Craven, J.D. Paige Duggins-Clay, J.D. Reymundo R. Flores, MBA Stephanie Garcia, Ph.D. Christie L. Goodman, APR, Fellow PRSA Chloe Latham Sikes, Ph.D. Makiah Lyons, J.D. Thomas Marshall III, M.Ed. Aurelio M. Montemayor, M.Ed. Celina Moreno, J.D. Lizdelia Piñón, Ed.D. Asaiah Puente, Ed.D., CNP Christina Quintanilla-Muñoz, Ph.D. Annet
Pharma Patent Filing Strategies That Maximize Exclusivity: The Complete IP Playbook - DrugPatentWatch – Transform Data into Market Domination --> --> --> --> --> --> --> --> --> Skip to content DrugPatentWatch - Transform Data into Market Domination Business Intelligence on Biologic and Small Molecule Drugs Blog Home DrugPatentWatch Home Pricing About Contact DrugPatentWatch - Transform Data into Market Domination Business Intelligence on Biologic and Small Molecule Drugs Blog Home DrugPatentWatch Home Pricing About Contact Pharma Patent Filing Strategies That Maximize Exclusivity: The Complet … ion per year is worth $250 million in revenue. A single well-timed continuation application, a pediatric study that earns six months of Pediatric Exclusivity, or a Patent Term Adjustment that recovers 400 days of USPTO delay can add hundreds of millions to a product’s net present value. These are not legal technicalities. They are financial decisions, and they belong in the strategic planning conversation alongside clinical trial design and regulatory pathway selection. … method-of-use expiry cluster, and the expected date of first ANDA or biosimilar application filing. The gap between those three dates, adjusted for litigation probability and regulatory exclusivity overlap, defines the commercial window. A drug with a 2027 primary patent expiry but a robust cluster of formulation and method-of-use patents extending to 2031, plus pediatric exclusivity through mid-2028, has a materially different NPV profile than its nominal expiry suggests. 2. … independently, and failure on any one of them is grounds for rejection or post-grant invalidation. Novelty means the invention has not been publicly disclosed in any form, whether through a conference presentation, a poster, an abstract, a published paper, or even an informal conversation with colleagues outside a confidentiality agreement, before the filing date. The United States operates under a 12-month grace period for inventor disclosures, meaning a researcher who publ … ffold or compound concept, before any public disclosure, and use the continuing application system to layer in the optimized compound and additional data as prosecution proceeds. Filing too early creates a different problem. A composition-of-matter patent filed before clinical proof-of-concept will have consumed years of term by the time the drug
End User License Agreement | SecPod | SecPod Buy Now Security Trust Center Schedule a Demo Free Trial Platform Research Learn Customers Partners Support Company Legal End User License Agreement Last updated May 21, 2026 Overview SECPOD END USER LICENSE AGREEMENT PLEASE READ THE TERMS AND CONDITIONS OF THIS LICENSE AGREEMENT (“AGREEMENT”) CAREFULLY BEFORE USING THE SOFTWARE (AS DEFINED BELOW). THIS IS A LEGALLY BINDING CONTRACT BETWEEN YOU AND SECPOD TECHNOLOGIES PVT. LTD. A.S., A COMPANY INCORPORATED UNDER THE COMPANIES ACT 1956 OF INDIA, HEREIN AFTER REFERED AS (“SECPOD”). BY ASSENTING ELECTR … this Agreement, your possession, installation and use of the Software does not grant you any rights or title to any intellectual property rights in the Software or Documentation. All rights to the Software and Documentation, including all associated copyrights, patents, trade secret rights, trademarks and other intellectual property rights are reserved by SECPOD. 5. RESTRICTIONS You agree that SECPOD Proprietary Intellectual Property is the sole property of SECPOD (or its li … thereof. Nothing contained in this Agreement or otherwise shall be construed to grant you any right, title, license or other interest in, to or under any SECPOD Proprietary Intellectual Property (whether by estoppel, implication or otherwise). You may not copy or use the Software or the Documentation except as set forth in Section 3 of this Agreement. You may not remove any proprietary notices on the Software; any copies that you are permitted to make pursuant to this Agreeme … this Section 8. The Receiving Party's confidentiality obligations will not apply to information which the Receiving Party can document: (i) was rightfully in its possession or known to it prior to receipt of the Confidential Information; (ii) is or has become public knowledge through no fault of the Receiving Party; (iii) is rightfully obtained by the Receiving Party from a third party without breach of any confidentiality obligation; or (iv) is independently developed b … omputer that may adversely affect its functionality, such as deleting system or application files identified malicious or vulnerable by the Software. You acknowledge and agree to such changes to your computer that may occur because of your use of the Software. The Software is not fault-tolerant and as such is not designed for use in hazardous env
EX-10.19 21 d386058dex1019.htm COLLABORATIVE RESEARCH AND LICENSE AGREEMENT Collaborative Research and License Agreement Exhibit 10.19 Execution Copy COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between WARNER CHILCOTT COMPANY, INC. and PARATEK PHARMACEUTICALS, INC. July 2, 2007 Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Secretary of the Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended. TABLE OF CONTENTS   … parately with the Secretary of the Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended. COLLABORATIVE RESEARCH AND LICENSE AGREEMENT This Collaborative Research and License Agreement (this “Agreement”) is made and entered into as of July 2, 2007 (the “Effective Date”) between Paratek Pharmaceuticals, Inc., a Delaware corporation with offices at 75 Kne … parately with the Secretary of the Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended. 1.3 “ Alliance Manager ” means the person appointed by each Party to serve as such Party’s principal coordinator and liaison for the conduct of the Backup Compound Research Programs and the Development of Lead Candidates and Products. The Alliance Manager appointed by WCCI i … parately with the Secretary of the Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended. 1.13 “ Clinical Trial Data ” means all data, results and information produced in the conduct by or on behalf of WCCI of any Clinical Trials. 1.14 “ Commercialization ” or “ Commercialize ” means, with respect to a Product, any and all activities directed to th … clude, without limitation, the approval of any NDA, sNDA or other Drug Approval Application. 1.18 “ Confidential Information ” means (a) with respect to Paratek, all tangible embodiments of Paratek Technology, (b) with respect to WCCI, all tangible embodiments of WCCI Technology and (c) with respect to each Party, (i)&nbs
Carlos Pantoja - Sr. Director Clinical Research, Oncology at Vir Biotechnology | The Org Platform Enrich Pricing Log in Sign up Vir Biotechnology Carlos Pantoja Unverified Carlos Pantoja Sr. Director Clinical Research, Oncology Contact Carlos Pantoja, MD, PhD, currently serves as Program Executive and Senior Director of Clinical Research in Oncology at Vir Biotechnology, Inc., since September 2024. Previous roles include Clinical Research Director at Sanofi, Medical Director at Amunix Pharmaceuticals, and various positions at Circumvent Pharmaceuticals and Perspectum Ltd. Additionally, Carlo
ONE NIGHT ONLY | 7A*11D Skip to content MENU MENU Home About Archives TPAC Programming: Archives by Year Archives by Artist Posts Subscribe to TPAC’s mailing list Search for: Search ONE NIGHT ONLY Canada 2004 LIFE=ART=LIFE 2004 LIFE=ART=LIFE --> One Night Only, Home Repair Fado 2004 PHOTO Miklos Legrady Artist discussion (with LIFE=ART=LIFE participants Tehching Hsieh, Louise Liliefeldt, Richard Martel & Kristine Stiles) Sunday February 22 2 pm Karen Schreiber Gallery Presented by Blank Slate with the support of 7a*11d International Festival of Performance Art; participation of One N … imation and web art contain a common thread of humour. She recently completed a residency at the University of Regina. Her most recent work, what we have here is a failure to , is an electronic installation that explores the concept of communication breakdown. FADO’s artist page for One Night Only Eyewitness account of the discussion by Daniel Baird Mail Facebook Instagram Twitter Site Map Privacy Policy Copyright © 1997 - 2026 Toronto Performance Art Collective Website
Circumvent | The Org Platform Enrich Pricing Log in Sign up Circumvent 0 followers Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Industries Pharmaceutical Headquarters Portland, United States Employees 1-10 Links Org chart Teams Offices Positions ( 6 ) Unverified Org chart AL Andrew Lim CEO 1 AL Andrew Lim Collapse Daniel Chelsky Chief Scientific Officer 0 Teams Ad
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL) - Andrew Lim Toggle navigation Home Search Services Blog Contact About Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL) Lim, Andrew Steiner, Robert David Wiley, Devin Thomas Circumvent Pharmaceuticals, Inc., Portland, CA, United States Search grants from Andrew Lim Search grants from Robert Steiner   … vin Wiley Search grants from Circumvent Pharmaceuticals, Inc. Share this grant: : : Abstract Funding Institution Comments Recent in Grantomics: Your institution vs. funders. Who wins? Read more... How should you pick the next fundable research topic? Read more... Recently viewed grants: Imaging Probe Development Center Renal Endothelial Dysfunction in Salt-Sensitive Hypertension Phospholipid Metabolism and Membrane … ess Innovation Research Grants (SBIR) - Phase I (R43) Project # 1R43NS100233-01 Application # 9254294 Study Section Special Emphasis Panel (ZRG1-ETTN-M (11)B) Program Officer Morris, Jill A Project Start 2017-03-01 Project End 2017-11-30 Budget Start 2017-03-01 Budget End 2017-11-30 Support Year 1 Fiscal Year 2017 Total Cost $198,790 Indirect Cost Institution Name Circumvent Pharmaceuticals, Inc. Department Type Domestic for-Profits DUNS # 080077073 City Portland State … ted States Zip Code Comments Be the first to comment on this grant Share this grant: : : Search © 2015 Grantome : Privacy policy : Terms & Conditions Follow us on: : :
Andrew Lim - CEO at Circumvent | The Org Platform Enrich Pricing Log in Sign up Circumvent Andrew Lim Unverified AL Andrew Lim CEO Contact No bio yet Org chart View org chart View position Daniel Chelsky Chief Scientific Officer Teams View all teams Executive Leadership 2 people, 0 jobs Offices View all offices This person is not in any offices Related people Jarand Rystad Rystad Energy Gianni Furino NOWDiagnostics Tarvo Topolev RebelRoam Randall J. Krause Eplace Sathish Kumar BigilToks Xavier Lernould Novity View more Company About Contact Blog Business Solutions Trust Pricing Directory Com
Circumvent Pharmaceuticals Inc | www.inknowvation.com --> --> --> --> --> --> --> > https://gasparesganga.com/labs/jquery-loading-overlay/#examples --> > https://gasparesganga.com/labs/jquery-loading-overlay/#examples --> Skip to main content idi Toggle navigation 0 You have 0 notifications Site Visitor Site Visitor New To Inknowvation.com? Register now to get an access to proprietary SBIR-STTR databases! Registration is fast and free - start your access to business-actionable information today! Login Site Register Home My Work Area About My Work Area SBIR Community About SBIR Community SBIR A … l molecule therapies for Neuronal Ceroid Lipofuscinosis Year Founded 2017 First Award 2017 Latest Award 2022 Program Status Active : At least one SBIR-STTR award (Phase I or Phase II) in last five years Inactive : Last award dollars more than FIVE years ago"> Program Status Active Popularity Index The Popularity Index is a rank (scale 1-100) assigned to each SBIR company, based on the number of hits to the company record. Currently Most Popular - click the name to see - … ease. Funded by NIH/NINDS, YC Bio, Heritage Provider Network, and the Longevity Fund and founded with seed funding from the Center for Advancing Innovation and Heritage Provider Network, Circumvent Pharmaceuticals is focused on the high, unmet need of Batten patients - Batten disease being a collection of rare and fatal diseases with progressive neurological decline. The focus of Circumvent Pharma is a pre-clinical therapy for Infantile Neuronal Ceroid Lipofuscinosis, type CL … password. Please enter email address that is associated with your account. Back Submit ' type='hidden'> Still Need Help? If you need further assistance, send us an e-mail and we will assist you in resetting your account. Forgot password? Mail sent successfully. Enter username and password. Please enter email address that is associated with your account. Back Submit ' type='hidden'> Still Need Help? If you need further assistance, send us an e-mail and we will assist you in re
NMS Labs Release: New Synthetic Drugs Circumvent DEA Scheduled Chemicals Found in Synthetic Cannabinoids - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Pharm Country NMS Labs Release: New Synthetic Drugs Circumvent DEA Scheduled Chemicals Found in Synthetic Cannabinoids February 15, 2012 | 1 min read Twitter LinkedIn Facebook Email Print WILLOW GROVE, Pa.--(BUSINESS WIRE)--There is no sign of a slowdown in the appearance of new drugs in the illicit designer drug pipeli … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Propanc Biopharma’s Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business Propanc Biopharma’s Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP December 13, 2023 | 4 min read Twitter LinkedIn Facebook Email Print Propanc Biopharma, Inc. today announced that the Company’s joint researcher, Mrs. Belén Toledo Cutillas, has comme … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Jamie Dimon's Letter to Shareholders, Annual Report 2025 | JPMorganChase Skip to main content Join our team Search JPMorganChase About us About us How we do business Leadership Awards and recognition Technology Governance Suppliers Diversity, opportunity & inclusion Read more Chairman and CEO Letter to Shareholders Learn more Impact Impact Global impact U.S. impact Latest news An Ohio-based company is protecting first responders around the world With support from JPMorganChase, Fire-Dex is providing protective equipment to firefighters in 100 countries and all 50 states. Learn more Com … k with us Grow with us How we hire Explore opportunities Students and graduates Apply now Latest news Veteran’s Unconventional Path to Landing her Dream Job in Tech U.S. Army Veteran Ashley Wigfall transitioned to a civilian role and charted her path to technologist through mentorship and skills training at the JPMorgan Chase tech hub in Plano, Texas. Learn more Investor Relations Investor Relations Senior Executive Letters Annual Report Quarterly Earnings Press releases Even … n related to the net gain on Visa shares and the donation of Visa shares to pre-fund contributions to the Firm's Foundation. ROTCE excluding Visa gain (net of contribution) was 19.9% for 2024 . Tangible Book Value and Average Stock Price per Share 2005–2025 See Text Version Chart Title : JPMorganChase Stock Price Range, Average Stock Price, and Tangible Book Value Per Share, 2005–2025 Units : All values in U.S. dollars per share. Key Highlight : 10% Compound Annual Growth … active management capabilities, enhancing our alternatives and exchange-traded fund platforms, expanding our international footprint and adding Global Private Bank advisors. You can read about these plans more specifically in the CEO letters. Our ongoing success will require us to up our game — and in multiple ways . We need to do a better job of utilizing our data to help the customer. We must develop products quicker and always look at the adjacencies that can make a custo … 2 surcharge has been driven by growth in the overall economy. Under the GSIB re-proposal, our surcharge would only decrease very modestly, to about 5.0%. This is absurd when we compare it with our 2015 Method 2 surcharge of 3.5%, and even more absurd when compared with our Method 1 surcharge of 2.5%, which has been flat versus inception. A proper
Cooperation between the UN and Regional and Sub-Regional Organisations: Debate on the Partnership with the AU : What's In Blue : Security Council Report Security Council Report Subscribe to receive our publications Follow us on Twitter Monthly Forecast Monthly preview of issues in the Council Country and Regional Issues Publications on country-specific and regional issues in the Council Thematic and General Issues Council thematic and structural issues and peace making, keeping and building About the UN Security Council Background information on the Council, its subsidiary bodies and activitie … the situations in West Africa and the Sahel and in the Great Lakes region; the application of sanctions in conflict situations in Africa; and the longstanding issue of securing adequate, predictable and sustainable financing for AU-led peace support operations. This meeting will be preceded by the seventh informal joint seminar of the two Councils, which is set to take place on 13 October. At the seminar, the two Councils will exchange views on how to enhance cooperation in … promise, Council members agreed to language requesting the Secretary-General to submit, by 30 April 2023, a report on progress made by the UN and the AU to fulfil the commitments set out in resolution 2320 of 8 November 2016 on cooperation between the UN and regional and sub-regional organisations and resolution 2378 of 20 September 2017 on peacekeeping reform. The report is also expected to include “recommendations on moving forward that reflect good practices and lessons-le
%PDF-1.6 %���� 1909 0 obj >stream hVmo�6�+�����N�@�v��@�P��� 4[��ɒ!1C��� �س��M? �����x��H�e� &�L2�_1)-�i'�0�(M��%�A�&�gJ GTƔ�����d5P�%��!�S.X��=�Pt��*������ �+����.�U�.L��YI�o.��!��c�'�y�7T��~_��)~�� gb�/��E��QV��㟑��ɤ�n�/u s�����o�ݝ��YԊG�=jQ0���*�kfS�*f�dN:�PJ�c�0���9�ՠ���B�+���Pkɋ�8uǬ��� bD�'���!��MQ��U; ��EH�J!�+ "%�Jf�D��� �^-�)m]�Y�Y����M)o�$����3� �F��� �o�]�l �v�w'�^�#�$C�>؇� ���H 5����+@�ǐn��HO��f�қ#@7�]�� ��ъ�E �[���= �:A8�-�-�4�&�,�͖M�}��z]`����. �6���̘�/�S��Y�F�R�*A *���v0 ��� �;i��7�%fpDL�l� �P����A�% � U�E�q��q�֏�� F�4;� … k��)�J4K���5�%1�����@��N�}��B�Wx���? L�^ endstream endobj 52 0 obj >stream application/postscript Print ARIE 2021-01-12T20:45:09-08:00 2021-01-12T20:45:09-08:00 2021-01-12T20:45:09-08:00 Adobe Illustrator 25.1 (Windows) xmp.iid:60264206-257d-174a-92e3-592fa74babbc xmp.did:60264206-257d-174a-92e3-592fa74babbc uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:F77F1174072068118A6DC29F0CD62520 xmp.did:F77F1174072068118A6DC29F0CD62520 uuid:5D20892493BFDB11914A8590D31508 … C29F0CD62520 2012-04-17T16:08:17-07:00 Adobe Illustrator CS5.1 / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:60264206-257d-174a-92e3-592fa74babbc 2021-01-12T20:45:09-08:00 Adobe Illustrator 25.1 (Windows) / Print False False 1 11.000000 8.500000 Inches Black Default Swatch Group 0 White CMYK PROCESS 0.000000 0.000000 0.000000 0.000000 Black CMYK PROCESS 0.000000 0.000000 0.000000 100.000000 CMYK Red CMYK PROCESS 0.000000 100.000000 … bj >stream x�]��j�0E�� -�E�K�S0� >stream x�m�� �P�z�[������J�� L�,X >stream application/pdf 2024 Annual Report Letter and 10-K 2025-02-14T22:06:46Z Workiva 2025-03-27T13:16:43-04:00 2025-03-27T13:16:43-04:00 Wdesk Fidelity Content Translations Version 011.002.024 uuid:5f0191dd-9e59-ca42-b237-ebc23f2a071b uuid:d425d8ee-91ac-c54a-822f-60271bff263a endstream endobj 1860 0 obj >>> endobj 1863 0 obj >stream H���Io 7���+xLCq_����l$����D���bx����|E��)����z�,��^U��2*֠r��� … roup 0 Amgen Blue PROCESS 100.000000 CMYK 91.000003 43.000001 0.000000 0.000000 application/pdf AmgenLogo_White uuid:30993db2-fa61-4dc9-a4e2-97d1d0e92105 uuid:7f6b500a-ce0f-cf42-8d44-8f75a95c2a67 xmp.did:072b2d5f-4286-41a5-8807-c191837b3445 proof:pdf saved xmp.iid:FCF793AC1157E0119DE4B4B759B0FC87 2011-03-25T11:57:04-07:00 Adobe Illustrator CS5 /
%PDF-1.6 %���� 1484 0 obj > endobj xref 1484 36 0000000016 00000 n 0000004462 00000 n 0000004681 00000 n 0000004719 00000 n 0000005848 00000 n 0000006054 00000 n 0000006169 00000 n 0000006718 00000 n 0000007272 00000 n 0000007786 00000 n 0000008352 00000 n 0000009007 00000 n 0000009742 00000 n 0000010139 00000 n 0000010346 00000 n 0000010998 00000 n 0000011379 00000 n 0000011693 00000 n 0000012007 00000 n 0000012714 00000 n 0000013362 00000 n 0000019301 00000 n 0000019814 00000 n 0000056355 00000 n 0000056396 00000 n 0000056640 00000 n 0000056724 00000 n 0000056781 00000 n 0000056856 00000 n 0 … ����մ�����1�� EKv`_ aatS3�ї��� �������R78Th1W � F�H��K�ʠv� >stream application/pdf Bio 2024-12-06T14:03:11+05:30 2024-12-06T14:03:11+05:30 2024-12-06T14:03:09+06:30 Adobe Illustrator 28.6 (Windows) uuid:317685be-3669-4d0d-b91e-151b810205a1 xmp.did:de43a278-e8a2-174d-b527-bab29cb7a17e uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:c9914b06-205d-4060-b620-fae57f2f5102 xmp.did:526773d2-a98f-654f-bf01-cbbe9b3a6f9d uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf … -a089-afc4dd30053e 2023-01-26T15:20:58-03:00 Adobe Illustrator 26.5 (Windows) / application/pdf kpmg_logo Martin Schulz Adobe PDF library 16.07 D:20220309122121 2019-07-05T11:46:29.7258506Z kpmgch 637056940225888304 637371472089537016 en-US Credit Suisse Zurich 2020-03-25 1 False False 595.320007 841.919983 Points Black Standard-Farbfeldgruppe 0 K=100 PROCESS 100.000000 CMYK 0.000000 0.000000 0.000000 100.000000 Document AIRobin endstream endobj 327 0 obj > endobj 328 0 obj > … 923e0cc3bc4 xmp.did:936b0bb4-e860-0c43-8d08-f5d963549875 default converted from application/x-indesign to application/pdf Adobe InDesign 17.4 (Windows) / 2024-01-29T06:49:01-03:00 application/pdf 01_Intro EN.indd Adobe PDF Library 16.0.7 False PDF/X-1:2001 PDF/X-1:2001 PDF/X-1a:2001 endstream endobj 398 0 obj > endobj 399 0 obj > endobj 400 0 obj >/PageTransformationMatrixList >/PageUIDList >/PageWidthList >>>>>/Resources 401 0 R/Rotate 0/TrimBox[0.0 0.0 595.276 841.89]/Type/ … [����6����0,�ʽ�w������f��fM=��n�v��-�g�]��JC�4{�}���wlU;b���1 �Ͽ� >stream application/pdf Diversity_Pie_Charts_Board 2024-12-17T06:19:22-03:00 2024-12-17T06:19:22-03:00 2024-12-17T06:19:21-02:00 Adobe Illustrator 28.7 (Windows) uuid:44d026b8-1e22-4ee2-a03f-6dc9cdf0eda0 xmp.did:5BAA041FC3C3E711A347E7CDD705395E uuid:5D20892493BFDB11914A8590D3
%PDF-1.7 %���� 17906 0 obj > endobj 17925 0 obj >/Filter/FlateDecode/ID[ ]/Index[17906 30]/Info 17905 0 R/Length 94/Prev 10544971/Root 17907 0 R/Size 17936/Type/XRef/W[1 2 1]>>stream h�bbd``b�T ���B �Z $��A�3�`v� �c� ���A,k9��IH�|����" 1�&�k#�xFb��{8�= endstream endobj startxref 0 %%EOF 17935 0 obj >stream h��V}L[�?����vK���B�q��,8bݣ!amJ) (4�]C�"� �Y ���L&��PC05( G� q��T:y����n�qC��Z֤d�v�{v@�?�wҞ�s�=�w��Z�@��4Ȱ�q���a[H�1x�%�,���OJ�� �����5� ��\�8��x��'rrTۯ��K���Q�mG��*�?��Ɠ ;��o�Yha/�S�Х[�TH�'8J��c�-1� ј�IuoI��J��o����F��Y�� ��TR1s�M�t�) Gܛ7BG2?�lU … {�x�58R��灜�I�T7��W�e�7�!� I���� �7Ȟ[9��SrUQ�f�G�e�(e���l}�Oh��y���[ �P� .@ ܐRFp�i��Ci�iB4��I��NL��T�;�0���)g* ��0� �7$���ܛ��N+u�8�cqB�tS|�X�dM�bl�h8 �QᎻ_��r}3����+MLa�����#���L�v�D�� t�&LCdR΅pcL>�� �9��2�e �i!Q���5�^3��*������ _7� ,Ͳg�*uj��~���w�jn��Μ�O�+ �!�}�� �ks��'��α[p�Ի��UZ�r�7� +R^ �]�#���u�K ,8l����s �����p�0 �d��}@�U�$� ���d�z�}���PfB�@\�C�%�&K`>����T��¬�c�����4�l�j��7�n�[��E�o��f����{�,�1I���=-�ilH)O�|���s�l �\f���� ɍK4�ub+��p … �>� �H���82��˳�?����>ҏ��ڇ5�#7C]އc�z ��e�Oc)�g�}.��"�r�e 0p9ƲUq�c >stream application/postscript AlnylamAssist_Reg_KO Jen Kaplan 2019-06-05T17:01:56-04:00 2019-06-05T17:01:56-04:00 2019-06-05T17:01:56-04:00 Adobe Illustrator CC 23.0 (Macintosh) xmp.iid:6f964ded-91d4-492d-80c9-5df5f883d90e xmp.did:6f964ded-91d4-492d-80c9-5df5f883d90e uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:e6c65106-3a86-4c43-b3aa-f7cabd5156c4 xmp.did:f69b95d0-f61c-46c1-b1b8-b32e7a7caca4 uuid … 1.388889 Inches Cyan Magenta Black Default Swatch Group 0 Document True AIRobin application/pdf access proof:pdf uuid:75d77470-032c-c649-a3c1-afcd1c79564f uuid:bb3bf67e-e98c-f543-9099-7667a3e5d8d6 Adobe PDF library 17.00 endstream endobj 99 0 obj >stream jP � ftypjp2 jp2 jpxbjpx rreq���@ .-jp2hihdr�]colrr�jp2c�O�Q)]��R �\@@HHPHHPHHPHHPHHP�� ��ϴ\����� ��ϴ\����� ��ϴ\����� ��ϴ\����� ��ϴ\����� ��ϴ\����� ��ϴ\��� … 7 Inches Cyan Magenta Yellow Black Default Swatch Group 0 Document True AIRobin application/pdf Newsweek_MostResponsible_2026_Logo_Basic proof:pdf uuid:610e158d-9bb6-cb41-a7ec-8c0e0336ac3d uuid:4670db68-061e-4f4c-8291-41c43559eb0f Adobe PDF library 17.00 endstream endobj 105 0 obj >stream Adobe Illustrator 29.8 (Macintosh) 2026-03-11T20:00:07-04:
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
abbv-20221231 0001551152 false 2022 FY http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#ResearchAndDevelopmentExpenseExcludingAcquiredInPr … 12 months (or for such shorter period that the registrant was required to submit such files). Yes   ☒        No  ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Large … , purity and potency. The types of data that could ordinarily be required in an application to show similarity may include analytical data, bioequivalence studies and studies to demonstrate chemical similarity, animal studies (including toxicity studies) and clinical studies. Furthermore, the law provides that only a biosimilar product that is determined to be "interchangeable" will be considered by the FDA as substitutable for the original biologic product without the interv … 60;percent of the period of time from the filing of an Investigational New Drug Application (NDA) for a 5 |    2022 Form 10-K                                                   compound to the submission of the NDA for such compoun … cant. If the NDA applicant studies the product for use by children, the FDA may grant pediatric exclusivity, which extends by 180 days all existing exclusivities (patent and regulatory) related to the product. For products that are either used to treat conditions that afflict a relatively small population or for which there is not a reasonab
Skip to content How It Works Pricing Blog Events Partners Search orgs, people, news, resources... ⌘K Sign In Get Started → Search organizations, people, news, resources, and content... / How It Works Pricing Blog Events Partners Sign In Get Started → Loading organizations... The OS for early-stage founders from day zero to raise. Subscribe Product How It Works Pricing Partners Resources Blog Events Contact Company About Privacy Terms © 2026 Startup Intros, Inc. San Francisco, CA · Made for Founders Circumvent: Funding, Team & Investors | Startup Intros Home / Organizations / Circumvent § P … nine total employees, the Portland enterprise has successfully secured federal grant funding from the Department of Health and Human Services to advance its proprietary research initiatives. Financial History Circumvent has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in June 2025. Raised $6.0M 1 funding round Funding Rounds Raised $6.0M raised Date Round Lead Investors Other Investors Status Jun 1, 2025 $6M Seed — Accel , ADA Ventures , C2 Invest
Opinion: Ohio lawmakers... - League of Women Voters of Ohio Facebook Log In League of Women Voters of Ohio's Post League of Women Voters of Ohio December 5, 2022 · Shared with Public Opinion: Ohio lawmakers will 'circumvent the will of the people' with school board bill Education isn't supposed to be a partisan issue. "Our elected state school board members serve the will of their constituents. They are not selected to serve at the pleasure of the governor's political party, which is no friend to public education." -Jeanne Melvin is a retired public school te
XBRL Viewer Please enable JavaScript to use the EDGAR Inline XBRL Viewer.
Sponsorship Policy - Mom 2.0 | Moms + Marketers + Media About Mom 2.0 Founders Team Inclusion Policy Sponsorship Policy Contact Ticket Policy Press Work With Us Insider Sessions Articles Small Biz Marketing + PR Digital + Social Content Creation Writing Self-Care Spotlights + Interviews Day of Wellness 2027 LAS VEGAS 2026 AUSTIN 2026 Sponsors 2026 Schedule 2026 Speakers *Buy Your Vegas Ticket* The Mom 2.0 Summit is an “open conversation between moms, media, and marketers.” We intend for all parties in that equation to meet on a level playing field to discuss industry best practices
%PDF-1.4 %���� 1128 0 obj > endobj xref 1128 108 0000000016 00000 n 0000003815 00000 n 0000004001 00000 n 0000004790 00000 n 0000005020 00000 n 0000005304 00000 n 0000005420 00000 n 0000005988 00000 n 0000012284 00000 n 0000012735 00000 n 0000016854 00000 n 0000017141 00000 n 0000017640 00000 n 0000018302 00000 n 0000018551 00000 n 0000018816 00000 n 0000019005 00000 n 0000019453 00000 n 0000023495 00000 n 0000023548 00000 n 0000023663 00000 n 0000023776 00000 n 0000024199 00000 n 0000028699 00000 n 0000033333 00000 n 0000033844 00000 n 0000036921 00000 n 0000041216 00000 n 0000041703 00000 n … 2131c71a547 xmp.did:62c8374e-99d0-465c-8432-3bde72c235af default converted from application/x-indesign to application/pdf Adobe InDesign CC 13.0 (Macintosh) / 2020-05-15T02:28:03+05:30 application/pdf Adobe PDF Library 15.0 False endstream endobj 1220 0 obj > endobj 1221 0 obj >stream endstream endobj 1222 0 obj >]/Filter[/DCTDecode]/Height 325/Length 88230/Metadata 1221 0 R/Subtype/Image/Type/XObject/Width 324>>stream ����Adobed�� … 3d955624dea xmp.did:62c8374e-99d0-465c-8432-3bde72c235af default converted from application/x-indesign to application/pdf Adobe InDesign CC 13.0 (Macintosh) / 2020-05-15T02:21:20+05:30 application/pdf Adobe PDF Library 15.0 False endstream endobj 4 0 obj > endobj 5 0 obj >stream endstream endobj 6 0 obj >]/Filter[/DCTDecode]/Height 270/Length 64177/Metadata 5 0 R/Subtype/Image/Type/XObject/Width 284>>stream ����Adobed�� … 3d955624dea xmp.did:62c8374e-99d0-465c-8432-3bde72c235af default converted from application/x-indesign to application/pdf Adobe InDesign CC 13.0 (Macintosh) / 2020-05-15T02:21:20+05:30 application/pdf Adobe PDF Library 15.0 False endstream endobj 41 0 obj > endobj 42 0 obj >stream 2020-05-15T01:23:30+05:30 2020-05-15T01:23:30+05:30 2020-05-15T01:23:30+05:30 Adobe InDesign CC 13.0 (Macintosh) uuid:efbb722e-7687-a546-b09b-b40b190df188 xmp.did:62c8374e-99d0-465c-8432-3bde72c235a … 3d955624dea xmp.did:62c8374e-99d0-465c-8432-3bde72c235af default converted from application/x-indesign to application/pdf Adobe InDesign CC 13.0 (Macintosh) / 2020-05-15T01:23:30+05:30 application/pdf Adobe PDF Library 15.0 False endstream endobj 43 0 obj > endobj 44 0 obj >]/Filter[/DCTDecode]/Height 349/Length 35313/Subtype/Image/Type/XObject/W
8.1.4 Determine the Allowability of Specific Financial Support or Sponsorship Payments to Outside Organizations - Business & Finance Confirmation Notification This website is no longer valid. Please go to BusFin.uillinois.edu. OK Cancel --> {1} ##LOC[OK]## Business & Finance About Applications Forms News Policies and Procedures Who to Ask Accounting & Budgeting Accounting & Financial Reporting Budget Financial Controls & Security Rate Schedules & Development Service and Storeroom Centers Sponsored Programs Buying & Contracts Procurement Laws & Regulations … nal Development Activities 8.6.5 Request Payment from a Registered Organization Fund 8.6.6 Request Scholarship Payments to Non-University of Illinois Students 8.6.7 Request Incentive Payment for Activity Participation 8.6.8 Refund Money to a Payee 8.6.9 Participant Support Costs 8.6.10 Postdoctoral Fellowship Payments 8.6.11 Electronic Codes as an Alternative Payment Method Reporting Foreign Bank Payments 8.7 Cell Phone & Data Plan Business Expenses 8.8.2 Request Payment … us of Checks Not Received by the Payee 8.8.4 Request a Check Cancellation 8.8.5 Submit 50 or More Payment Requests Electronic Disbursements 8.9.1 Request an Exception 8.10 Process Educational Payments to Students 8.11 Relocation Assistance 8.12.1 PCard Program 8.12.2 PCard Roles and Responsibilities 8.12.3 Reconcile and Audit a PCard 8.12.4 Restricted & Prohibited PCard Purchases 8.12.5 Inappropriate PCard Use 8.12.6 Request a PCard Exception Last item for navigation 8.1. … ort payment is in compliance with the donor intent restrictions assigned to the fund), or self-supporting funds (when directly related to generation of the fund’s revenue). State funds cannot be used for financial support or sponsorship payments. As a general rule, the system is required to report financial support or sponsorship payments as taxable income on IRS Form 1099-MISC if the cumulative value paid to the Recipient over the calendar year equals or exceeds $600. See IR … proval and signature cannot be delegated. A contract is required. The unit must submit the contract request for processing to the appropriate PCM using the Contract Request Form within Contracts+. The request must include the signed Financial Support/Sponsorship Payment Form . This form requires Adobe Acrobat Reader and will not work with some br
Deconstructed: Medicare Drug Pricing Negotiations Advance Skip to main content Support Us Support Us Iran Midterms Justice War on Gaza Unmasking ICE Chilling Dissent Support Us Special Investigations Voices Podcasts Press Freedom Defense Fund Join the Newsletter About Contact Us More Ways to Donate Impact & Reports Jobs Become a Source © THE INTERCEPT ALL RIGHTS RESERVED Terms of Use Privacy Iran Midterms Justice War on Gaza Unmasking ICE Chilling Dissent About Support Us Medicare Drug Pricing Negotiations Advance Alex Lawson and Ryan Grim discuss the decadeslong struggle against Big Phar
Thailand--lighting up a dark market: British American tobacco, sports sponsorship and the circumvention of legislation Thailand--lighting up a dark market: British American tobacco, sports sponsorship and the circumvention of legislation J Epidemiol Community Health . 2007 Jan;61(1):28-33. doi: 10.1136/jech.2005.042432. Authors Ross MacKenzie 1 , Jeff Collin , Kobkul Sriwongcharoen Affiliation 1 London School of Hygiene and Tropical Medicine, Keppel Street, London, UK. [email protected] PMID: 17183011 PMCID: PMC2465596 DOI: 10.1136/jech.2005.042432 Abstract Objectiv
Circumvent raises $6M to tackle cloud security alert fatigue with AI-driven remediation - Tech Startups Home Executive Interviews Startups Advertise About Trust & Safety Editorial Policy June 26, 2026 Home Executive Interviews Startups Advertise About Trust & Safety Editorial Policy Topics Search Startups Top Startups Startup List Submit Your Startup Tools Free Startup Valuation Calculator Home » Artificial Intelligence Cloud Cybersecurity Featured Security Startup Funding Startup Spotlight Startups Tech Startup News Tech Startups Technology News Circumvent raises $6M to tackle cloud
Brands get creative to circumvent FIFA's strict sponsorship rules Sign In Home News Politics White House Senate House Campaigns Policy 2026 Election Opinion Editorials Op-Eds In Focus Restoring America Magazine Watch Sponsored Powering Progress ASAE – Association Leadership Examining Tax Reform Fix TSCA National Parks Inside the Corn Belt Examining Transportation TWS Archive Search Washington Examiner Subscribe Advertisement Search Washington Examiner Sign in Subscribe News Politics Trump Administration White House Senate House Campaigns Business World Investigations Justice Supreme
Discovery of 2',4'-dimethoxychalcone as a Hsp90 inhibitor and its effect on iressa-resistant non-small cell lung cancer (NSCLC) Discovery of 2',4'-dimethoxychalcone as a Hsp90 inhibitor and its effect on iressa-resistant non-small cell lung cancer (NSCLC) Arch Pharm Res . 2015 Oct;38(10):1783-8. doi: 10.1007/s12272-015-0595-6. Epub 2015 Apr 9. Author Young Ho Seo 1 Affiliation 1 College of Pharmacy, Keimyung University, Daegu, 704-701, Korea. [email protected]. PMID: 25855012 DOI: 10.1007/s12272-015-0595-6 Abstract Heat shock protein 90 (Hsp90) is a ATP dependent mole
%PDF-1.6 %���� 320 0 obj > endobj 339 0 obj >/Filter/FlateDecode/ID[ ]/Index[320 30]/Info 319 0 R/Length 97/Prev 165708/Root 321 0 R/Size 350/Type/XRef/W[1 3 1]>>stream h�bbd```b``� �� D���H�(0� D��I�J�� 0� I�lB,X�2��� $+ @�8 �?Ҋ����� >stream h�b```�r-A��1�� ��Y2�q���������pJJ� �*�d'ō�8f\��)v24 ������*S�T@�Y�5v endstream endobj 321 0 obj >/Metadata 35 0 R/Outlines 48 0 R/Pages 318 0 R/StructTreeRoot 53 0 R/Type/Catalog>> endobj 322 0 obj >/Font >>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 323 0 obj >stream h�Ėmo�6ǿ _��PH�+�fX�.��P!�����N-�N� … d791232-e2bb-49f5-8102-f845af046ec4 uuid:867b483a-4488-4f6e-a148-f909e86b1498 6 application/pdf Misty Kuryliw Adobe PDF Library 15.0 D:20210913220402 endstream endobj 31 0 obj >stream 2021-09-13T15:05:38-07:00 2021-09-13T15:05:37-07:00 2021-09-13T15:05:38-07:00 Acrobat PDFMaker 15 for Word uuid:c37aee84-7f63-459a-8358-1a15fae134a9 uuid:2ea95741-abc9-4304-808e-137b11c60707 21 application/pdf Misty Kuryliw Adobe PDF Library 15.0 D:20210913050302 endstream endobj 32 0 obj >strea … 021-09-13T15:09:58-07:00 2021-09-13T15:09:58-07:00 Acrobat PDFMaker 15 for Word application/pdf Misty Kuryliw uuid:f53fe59a-1fed-4268-8867-fac81030e3c0 uuid:80caffd2-62d0-4d28-a6ad-30ec14dd159e Adobe PDF Library 15.0 endstream endobj 36 0 obj >stream h�26�P0P���w�/�+Q����L)�662�)�Ic0i &���%D" Q� RY�� ���Zlg`fRI endstream endobj 37 0 obj >stream h�|�� �@��W���(g)CIژ � �M�7�#2o������wb�2β,,f�@�k=˪�l�� >/Filter/FlateDecode/ID[ ]/Info 319 0 R/Length 175/Root 321 0
Saudi Arabian government-owned bank takes stake in HBG PEI Infrastructure Investor News and Analysis Data Performance and rankings Network & Events Sectors Regions Saudi Arabian government-owned bank takes stake in HBG Middle Eastern private equity firm HBG Holdings has sold a management company stake to a private equity fund of The National Commercial Bank of Saudi Arabia, as Middle Eastern governments continue to buy into the asset class. By Toby Lewis 16 January 2013 • 2 mins read Deals Fundraising People Middle East North America Joint Ventures Venture Capital Regulation Fundraising to … or 100 Latest news Fundraising Pantheon’s infra secondaries surpasses target as fund sizes build 6 hours ago · 3 mins read News & Analysis Infra funds herald Uniper’s phoenix moment 24 June 2026 · 3 mins read Trends Why AllianzGI is increasingly focused on infra secondaries 24 June 2026 · 3 mins read View all Upcoming events SEP 15 Infrastructure Investor: Investor Forum London 2026 London NOV 04 Infrastructure Investor America Forum 2026 New York DEC 02 Infrastructure St
A cybersecurity founder who had a $100 million exit is back with a new idea and a $9.2 million Seed round from Paladin Capital - Startup Daily Get the best of Startup Daily straight to your inbox Subscribe News, Insights and Stories from the Australian and New Zealand tech ecosystem. Log in View all search results Search News Topic Accelerator Ag tech AI/Machine Learning ASX Business Climate Tech Cryptocurrency Cyber security Data Events Fintech Funding Global tech Other tech People Politics Quantum Computing Social Media Space Venture Capital Women in tech Advice Business strategy Diversity I … e drowning in alerts from security tools spread across their infrastructure and application stack. Circumvent leverages AI and machine learning to ingest, correlate, and enrich alerts from cloud-native, open-source, and third-party security tools. Get the best of Startup Daily straight to your inbox Want to know the latest in startup news? Subscribe to our daily news and analysis coverage on what’s happening to ANZ startups, investors and the broader ecosystem. And best of al
--> Home | Mysite top of page Home About Patients Investors Team More Use tab to navigate through the menu items. ABOUT APPROACH PATIENTS INVESTORS INVESTORS PARTNERS TEAM TEAM CONTACT CIRCUMVENT Developing precision medicines for neurodegenerative disease ABOUT ABOUT In the next 20 years, neurodegenerative disease is expected to overtake cancer as the second leading cause of death worldwide. At the same time, progress in developing disease-modifying treatments has been slowed by the lack of novel insights into driver mechanisms of disease. Circumvent was formed with the mission of developing
Federal Circuit Finds IPRs Can Circumvent Assignor Estoppel | Mintz Skip to main content Menu Why Mintz Meet Our Managing Member Our History Innovation Diversity Pro Bono Community Service Alumni Leadership Awards & Recognition International Law Firm Network In Memoriam Our People Our Services Insights Center Events News & Press Releases Alumni Careers Offices News Search Search Open Search Home All Federal Circuit Finds IPRs Can Circumvent Assignor Estoppel By Daniel B. Weinger On Wednesday, the Federal Circuit held that while assignor estoppel is applicable in district court proceedi … Apr. 22, 2020) highlights the potential unfairness from allowing the doctrine’s application in district court but not at the Patent Trial and Appeal Board (“PTAB”), and potentially presents an issue ripe for en banc review. In the 1990’s, Csaba Truckai founded NovaCept, a company that developed NovaSure, a medical device for detecting perforations in the uterus for endometrial ablations. Mr. Truckai also invented U.S. Patent Nos. 6,872,183 (the “ʼ183 patent”) and … this decision, en banc review may be necessary to address discrepancies in the application of assignor estoppel in district court cases and proceedings before the PTAB. Judge Stoll seemingly agrees, writing separately: “Given the odd circumstance created in this case, I suggest that it is time for this court to consider en banc the doctrine of assignor estoppel as it applies both in district court and in the Patent Office. We should seek to clarify this odd … oint Topics Intellectual Property Federal Circuit Appeals IPRs & Other Post Grant Proceedings Share Related Practices Federal Circuit Appeals IPRs & Other Post-Grant Proceedings Related Industries Consumer Products Author Daniel Weinger Sign up for Mintz Insights Get our latest thought leadership Find Solutions Practices Industries Why Mintz Get in Touch Offices Find an Attorney Careers Keep in Touch Insights Center News & Press Releases Events Follow us Footer Sitema
Subpart 17.5 - Interagency Acquisitions | Acquisition.GOV Skip to main content An official website of the United States Government Main navigation FAR Overhaul Regulations Row 1 FAR Smart Matrix Chapter 99 (CAS) Row 2 DFARS DFARSPGI AFARS DAFFARS DAFFARS MP DARS DLAD NMCARS SOFARS TRANSFARS Row 3 AGAR AIDAR CAR DEAR DIAR DOLAR DOSAR DTAR Row 4 EDAR EPAAR FEHBAR GSAM/R HHSAR HSAR HUDAR Row 5 IAAR JAR LIFAR NFS NRCAR TAR VAAR Tools Archives Smart Matrix Regulations Search Acquisition Regulation Comparator (ARC) Policy Network CAOC CAAC FAR Council ISDC Breadcrumb Home Regulations FAR Subpart 17. … tering a contract, a task order , or delivery order . (c) This subpart does not apply to- (1) Interagency reimbursable work performed by Federal employees (other than acquisition assistance), or interagency activities where contracting is incidental to the purpose of the transaction; or (2) Orders of $750,000 or less issued against Federal Supply Schedules. 17.501 General. (a) Interagency acquisitions are commonly conducted through indefinite-delivery contracts, such as task- … ss transaction does not result in a contract or an order, then the FAR does not apply. The Economy Act also provides authority for placement of orders between major organizational units within an agency; procedures for such intra-agency transactions are addressed in agency regulations. (b) The Economy Act applies when more specific statutory authority does not exist. Examples of more specific authority are 40 U.S.C. 501 for the Federal Supply Schedules (subpart 8.4 ), and 40 … writing . (d) When an interagency acquisition requires the servicing agency to award a contract, the following procedures also apply: (1) If a justification and approval or a D&F (other than the requesting agency ’s D&F required in 17.502-2 (c)) is required by law or regulation, the servicing agency shall execute and issue the justification and approval or D&F. The requesting agency shall furnish the servicing agency any information needed to make the justi … uirements. (a) The senior procurement executive for each executive agency shall submit to the Director of OMB an annual report on interagency acquisitions , as directed by OMB. (b) The contracting officer for the servicing agency shall ensure that service contractor reporting requirements are met in accordance with subpart 4.17 , Service Co
Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents Bioessays . 1991 Jan;13(1):31-6. doi: 10.1002/bies.950130106. Author R S Kerbel 1 Affiliation 1 Division of Cancer and Cell Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. PMID: 1722975 DOI: 10.1002/bies.950130106 Abstract Cancers have a formidable capacity to develop resistance to a large and diverse array of chemi
--> Home | Mysite top of page Home About Patients Investors Team More Use tab to navigate through the menu items. ABOUT APPROACH PATIENTS INVESTORS INVESTORS PARTNERS TEAM TEAM CONTACT CIRCUMVENT Developing precision medicines for neurodegenerative disease ABOUT ABOUT In the next 20 years, neurodegenerative disease is expected to overtake cancer as the second leading cause of death worldwide. At the same time, progress in developing disease-modifying treatments has been slowed by the lack of novel insights into driver mechanisms of disease. Circumvent was formed with the mission of developing
Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer Pharmacol Res . 2025 Feb:212:107611. doi: 10.1016/j.phrs.2025.107611. Epub 2025 Jan 18. Authors Jumin Huang 1 , Ziming Wang 1 , Feng Li 2 , Huiting Wang 2 , Yang Xiang 2 , Runze Li 3 , Chun Xie 1 , Yuwei Wang 4 , Zhihong Jiang 5 ,